PL230364A1 - - Google Patents

Info

Publication number
PL230364A1
PL230364A1 PL23036481A PL23036481A PL230364A1 PL 230364 A1 PL230364 A1 PL 230364A1 PL 23036481 A PL23036481 A PL 23036481A PL 23036481 A PL23036481 A PL 23036481A PL 230364 A1 PL230364 A1 PL 230364A1
Authority
PL
Poland
Application number
PL23036481A
Other versions
PL132428B1 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL230364A1 publication Critical patent/PL230364A1/xx
Publication of PL132428B1 publication Critical patent/PL132428B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1981230364A 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one PL132428B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (2)

Publication Number Publication Date
PL230364A1 true PL230364A1 (ko) 1982-03-29
PL132428B1 PL132428B1 (en) 1985-03-30

Family

ID=22465278

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Country Status (5)

Country Link
JP (1) JPS56150091A (ko)
KR (2) KR850000412B1 (ko)
PL (2) PL132428B1 (ko)
SU (1) SU1093251A3 (ko)
ZA (1) ZA812085B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
DE68926473T2 (de) * 1988-03-28 1996-10-02 Janssen Pharmaceutica Nv Mittel zur Konservierung oder Wiederherstellung der gesunden Haut
EP2252608A4 (en) * 2008-02-29 2012-10-03 Vm Discovery Inc METHOD FOR TREATING PAIN SYNDROME AND OTHER SUFFERING
EA037123B1 (ru) * 2012-02-10 2021-02-09 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения спинальной мышечной атрофии
EP3310169B1 (en) 2015-05-30 2023-05-17 PTC Therapeutics, Inc. Methods for modulating rna splicing
WO2017100726A1 (en) 2015-12-10 2017-06-15 Ptc Therapeutics, Inc. Methods for treatng huntington's disease
EP3544435A4 (en) 2016-11-28 2020-11-04 PTC Therapeutics, Inc. RNA SPLICE MODULATION PROCESSES
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
KR20200017476A (ko) 2017-06-14 2020-02-18 피티씨 테라퓨틱스, 인크. Rna 스플라이싱의 변경 방법
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
EP3644996B1 (en) 2017-06-28 2023-07-26 PTC Therapeutics, Inc. Methods for treating huntington's disease
WO2019191092A1 (en) 2018-03-27 2019-10-03 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
LT3814357T (lt) 2018-06-27 2024-06-25 Ptc Therapeutics, Inc. Heterocikliniai ir heteroarilų junginiai, skirti hantingtono ligos gydymui
EP3814360B1 (en) 2018-06-27 2024-10-02 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease

Also Published As

Publication number Publication date
KR830005220A (ko) 1983-08-03
PL132428B1 (en) 1985-03-30
PL233902A1 (ko) 1982-07-19
JPS56150091A (en) 1981-11-20
PL131162B1 (en) 1984-10-31
KR850000412B1 (ko) 1985-03-26
SU1093251A3 (ru) 1984-05-15
ZA812085B (en) 1982-11-24
JPH0215550B2 (ko) 1990-04-12
KR850000413B1 (ko) 1985-03-26

Similar Documents

Publication Publication Date Title
FR2475288B1 (ko)
FR2474700B1 (ko)
DE3152455A1 (ko)
FR2473281B1 (ko)
FR2474086B1 (ko)
FR2473151B1 (ko)
FR2475076B1 (ko)
FR2474256B1 (ko)
FR2473291B1 (ko)
FR2475170B1 (ko)
FR2475047B1 (ko)
CH647640GA3 (ko)
FR2473114B1 (ko)
FR2475380B1 (ko)
FR2474796B1 (ko)
FR2474075B3 (ko)
FR2474196B1 (ko)
FR2474055B1 (ko)
FR2475532B3 (ko)
FR2475266B1 (ko)
FR2474452B1 (ko)
FR2473146B1 (ko)
FR2473038B1 (ko)
FR2473085B1 (ko)
FR2475559B1 (ko)